1977New England Journal of MedicineRequires access

Bronchodilator Therapy

David C. Webb-Johnson, Joseph L. Andrews

Open publisher page 61 citations

Abstract

There may be as many different therapy programs for bronchospasm as there are physicians treating asthma, bronchitis and emphysema. This variety of programs results from the recent introduction of many new bronchodilator drugs, varying preferences of physicians and different responses by patients. We will review briefly recent information about the pathophysiology of bronchoconstriction, discuss the actions of the most useful bronchodilator drugs (listed in Table 1) and present a strategy for progressive treatment of increasing degrees of bronchospasm.Pathophysiology of BronchospasmThe abnormalities in the airways during an asthmatic attack include smooth-muscle spasm, plugging with viscid mucus and further obstruction from . . .

About this research paper

What this paper is about

There may be as many different therapy programs for bronchospasm as there are physicians treating asthma, bronchitis and emphysema. This variety of programs results from the recent introduction of many new bronchodilator drugs, varying preferences of physicians and different responses by patients. We will review briefly recent information about the pathophysiology of bronchoconstriction, discuss the actions of the most useful bronchodilator drugs (listed in Table 1) and present a strategy for progressive treatment of increasing degrees of bronchospasm.Pathophysiology of BronchospasmThe abnormalities in the airways during an asthmatic attack include smooth-muscle spasm, plugging with viscid mucus and further obstruction from . . .

Why it matters

OpenAlex reports 61 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

There may be as many different therapy programs for bronchospasm as there are physicians treating asthma, bronchitis and emphysema. This variety of programs results from the recent introduction of many new bronchodilator drugs, varying preferences of physicians and different responses by patients. We will review briefly recent information about the pathophysiology of bronchoconstriction, discuss the actions of the most useful bronchodilator drugs (listed in Table 1) and present a strategy for progressive treatment of increasing degrees of bronchospasm.Pathophysiology of BronchospasmThe abnormalities in the airways during an asthmatic attack include smooth-muscle spasm, plugging with viscid mucus and further obstruction from . . .

Key concepts: Bronchospasm, Medicine, Bronchodilator, Bronchoconstriction, Bronchodilator Agents, Intensive care medicine, Pathophysiology, Bronchodilation

Related papers

Back to paper searchBrowse research topicsOriginal source
Bronchodilator Therapy — Research Paper | ScholarLens